Sanofi S A | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Sanofi S A

Sort by

Viewing results 1‒25 of 79030

News updates from February 1: Meta announces first ever dividend, Bank of England holds interest rates
Sanofi sales dragged down by exchange rates and generic competition
...Sanofi’s operating income fell 5.2 per cent at the end of last year as adverse currency rates and generic competition with multiple sclerosis pill Aubagio hit sales....
February 1, 2024
Drugs research
Diabetes drug offers hope to Parkinson’s sufferers
...The drug is marketed by Sanofi as Lyxumia in the EU and Adlyxin in the US, where it was discontinued last year because of low demand....
April 3, 2024
FT Live
FTWeekend Festival: U.S. edition
Where the Financial Times weekend paper comes to life
Saturday, 4 MayThe REACH, at the Kennedy Center for the Performing Arts, F Street Northwest, Washington, DC, USA
LexSanofi SA
Sanofi: chief must prove he can win R&D game Premium content
...Sanofi insists it has 12 possible blockbusters in the pipeline, with a collective peak sales potential of €33bn to €60bn....
December 7, 2023
News updates from October 27: IDF expands Gaza ground operations, Fed’s preferred inflation gauge hits 2-year low
Sanofi explores consumer care spin-off
...The business accounts for just over a tenth of Sanofi’s total sales....
October 27, 2023
News in-depthSanofi SA
Sanofi chief says he could have done a better job outlining R&D plan
...Sanofi chief executive Paul Hudson has admitted he could have done a better job explaining aspects of a multibillion-euro investment plan to shareholders, ahead of a meeting where he will try to sell them...
December 7, 2023
Sanofi SA
French prosecutors examine claims of market manipulation against Sanofi
...Sanofi has since restructured its consumer division as a standalone business within the company....
November 7, 2023
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Sanofi SA
Sanofi shares fall 19% after cut to profit outlook
...Sanofi said a split of the consumer unit could take place as early as the end of next year, most likely through a listing in Paris....
October 27, 2023
European equities
Europe’s ‘Granolas’ fuel record stock market surge
...The Granolas as a group have climbed 18 per cent over the past 12 months beating the Stoxx 600’s 7.5 per cent rise over the same period....
February 23, 2024
LexJonathan Guthrie
The Lex Newsletter: science is where the magic happens Premium content
...For some pharma groups, notably Sanofi of France, the pandemic was a time of embarrassing and very public underperformance....
December 8, 2023
Global inflation
Will a second inflation wave turn the AI boom into a winter of discontent?
...For instance, just one tech company’s recent gains added the equivalent of the market capitalization of the bottom 100 companies in the S&P 500, and the size of the crypto market doubled since last fall....
February 22, 2024
Live news: S&P 500 and Nasdaq post fifth session loss in a row
S&P 500 and Nasdaq post fifth session loss in a row
...The benchmark S&P 500 fell 0.2 per cent on Thursday afternoon, notching five straight daily losses for the first time since October....
April 18, 2024
Live news: S&P 500 and Nasdaq post fifth session loss in a row
S&P 500 and Nasdaq post fifth session loss in a row
...The benchmark S&P 500 fell 0.2 per cent on Thursday afternoon, notching five straight daily losses for the first time since October....
April 18, 2024
Live news: Asian equities sell off amid tensions in the Middle East
S&P downgrades Israel’s long-term rating over ‘heightened geopolitical risk’
...S&P said it originally expected the war would not last “more than six months” as it downgraded Israel’s sovereign credit rating from double A minus to A plus....
April 19, 2024
Live news: Latest US IPOs bounce on debut
S&P 500 heads for first five-session losing streak since October
...The S&P 500 declined on Thursday, headed for its fifth straight loss since October....
April 18, 2024
Oliver Ralph
Let’s hear it for the FTSE 100’s magnificently unglamorous seven
...On a long-term view, some of the FTSE 100’s less glamorous members, companies such as Compass, Intertek, Relx, Experian and Diploma as well as Bunzl and Howdens, have performed far better than the household...
April 15, 2024
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Live news: S&P 500 falls for third straight week as Nvidia notches worst day since 2020
S&P 500 falls for third straight week as Nvidia notches worst day since 2020
...The blue-chip S&P 500 dropped 0.9 per cent on Friday, capping its longest losing streak since October 2022. It fell for the third week in a row, losing 3.1 per cent across five sessions....
April 19, 2024
Lex PopuliMarks & Spencer Group PLC
M&S ‘superapp’ will need a long shelf life
...M&S’s contract with HSBC, which owns M&S Bank, is up for renewal. M&S is likely to push for more control and a bigger cut of the spoils....
March 21, 2024
FT SeriesThe world’s best house museums
House museums #57: Pearl S Buck
...The Nobel and Pulitzer Prize-winning author Pearl S Buck amassed a personal library that fills two rooms of her 19th-century Pennsylvania farmhouse....
March 2, 2024
European companies
The increasingly silly search for Europe’s (less) Magnificent Seven
...Goldman Sachs gave it a go with the ‘Granolas’ or, more accurately, GRANNNLLASS: GSK, Roche, ASML, Nestlé, Novartis, Novo Nordisk, L’Oréal, LVMH, AstraZeneca, SAP, and Sanoﬁ....
March 6, 2024
News updates from March 25: Boeing CEO to step down; UN Security Council calls for Gaza ceasefire
S&P 500’s energy sector jumps as oil rises and Morgan Stanley turns bullish
...The bank’s upgrade follows its forecast last week that Brent crude prices will hit $90 a barrel by the third-quarter....
March 25, 2024
News updates from July 28: Bank of Japan tweaks bond buying strategy, Measures of US inflation and wage growth cool
Sanofi increases forecasts after strong immunology drug sales boost earnings
...Sanofi raised its full year earnings guidance after sales of its immunology drug Dupixent soared by more than a third in the second quarter....
July 28, 2023
LexPharmaceuticals sector
Big Pharma still needs trial success to overcome looming patent panic Premium content
...French rival Sanofi is fighting a similar battle despite upping R&D spend by around €700mn this year as it works to reduce its reliance on its asthma and eczema treatment Dupixient....
February 6, 2024
News updates from April 4: British billionaire avoids prison for insider trading; Italy seizes assets in EU fund fraud case
S&P 500 notches first gain of the second quarter
...The S&P 500 notched its first gain of the week, recovering from a back-to-back decline, as traders took in new data that indicated a softening US economy....
April 3, 2024
News updates from April 3: Iger defeats Peltz in Disney proxy war; Eurozone inflation falls to 2.4%
S&P 500 notches first gain of the second quarter
...The S&P 500 notched its first gain of the week, recovering from a back-to-back decline, as traders took in new data that indicated a softening US economy....
April 3, 2024
News updates from March 28: Sam Bankman-Fried sentenced to 25 years; US GDP growth in Q4 revised higher
S&P 500 notches best quarter in five years
...US blue-chips ended their best quarter in five years, with the S&P 500 squeezing out a 0.1 per cent gain even as big tech names including Apple, Tesla and Meta dragged the Nasdaq Composite to a similar-sized...
March 28, 2024

Previous pagePage 1 of 3162Next page